In this context, a fully human anti-IL7R antibody, which impaired IL-7/IL7R-mediated signalling, making T-ALL cells sensitive to chemotherapy, and promoting leukemia cell killing through a NK-mediated cytotoxicity, was generated [200]. The gene discussed is IL7R; the disease is leukemia.